StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly japan revenue ($M) ($M)

Form 10-Q / 10-K Geographic Information Note

QuarterlyAnnual
Latest, FY2025
2,132
Period ended Dec 31, 2025
Change on a year earlier
+17.5%
1,815 in FY2024
History
16 years
Since FY2010
Sources
11
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedJapan revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 20252,132+17.5%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 20241,815+8.5%Form 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 20231,673-4.3%Form 10-K (filed 2026-02-12) ↗
FY2022Dec 31, 20221,747-26.2%Form 10-K (filed 2025-02-19) ↗
FY2021Dec 31, 20212,367-8.4%Form 10-K (filed 2024-02-21) ↗
FY2020Dec 31, 20202,583+1.4%Form 10-K (filed 2023-02-22) ↗
FY2019Dec 31, 20192,548+5.8%Form 10-K (filed 2022-02-23) ↗
FY2018Dec 31, 20182,407+2.9%Form 10-K (filed 2021-02-17) ↗
FY2017Dec 31, 20172,340+0.4%Form 10-K (filed 2020-02-19) ↗
FY2016Dec 31, 20162,331+14.6%Form 10-K (filed 2019-02-19) ↗
FY2015Dec 31, 20152,033+0.3%Form 10-K (filed 2016-02-19) ↗
FY2014Dec 31, 20142,027-1.8%Form 10-K (filed 2015-02-19) ↗
FY2013Dec 31, 20132,064-8.1%Form 10-K (filed 2015-02-19) ↗
FY2012Dec 31, 20122,246+6.8%Form 10-K (filed 2015-02-19) ↗
FY2011Dec 31, 20112,104+30.2%Form 10-K (filed 2013-02-21) ↗
FY2010Dec 31, 20101,617–Form 10-K (filed 2013-02-21) ↗

Cite this data

StockData. (2026). Eli Lilly Japan revenue ($M) ($M), annual FY2010–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev_geo_japan

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.